Faes Farma(GB:0K9H)
€5.03-0.04 (-0.79%)
GB:0K9H
Faes Farma financials statements
€5.03
At close:-0.04 (-0.79%)
Faes Farma (0K9H) Ratios
2 Followers
Faes Farma Ratios
GB:0K9H's free cash flow for Q2 2026 was €34.83M. For the 2026 fiscal year, GB:0K9H's free cash flow was decreased by €-9.06M and operating cash flow was €43.90M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.61 | 3.23 | 3.34 | 3.32 | 3.70 |
| Quick Ratio | 1.61 | 1.85 | 1.86 | 2.11 | 2.36 |
| Cash Ratio | 0.63 | 0.62 | 0.40 | 0.70 | 0.89 |
| Solvency Ratio | 0.18 | 1.04 | 0.99 | 0.88 | 0.96 |
| Operating Cash Flow Ratio | 0.42 | 1.12 | 1.16 | 1.13 | 1.00 |
| Short-Term Operating Cash Flow Coverage | 2.49 | 58.08 | 5.84 | 4.03 | 6.54 |
| Net Current Asset Value | € -111.79M | € 207.26M | € 177.61M | € 189.82M | € 190.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.01 | 0.03 | 0.05 | 0.03 |
| Debt-to-Equity Ratio | 0.55 | 0.01 | 0.04 | 0.05 | 0.03 |
| Debt-to-Capital Ratio | 0.35 | 0.01 | 0.03 | 0.05 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.33 | 0.00 | 0.01 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.80 | 1.18 | 1.17 | 1.21 | 1.20 |
| Debt Service Coverage Ratio | 2.53 | 54.47 | 6.22 | 4.03 | 7.84 |
| Interest Coverage Ratio | 11.51 | 247.31 | 118.74 | 120.23 | 109.64 |
| Debt to Market Cap | 0.25 | 0.00 | 0.02 | 0.02 | 0.01 |
| Interest Debt Per Share | 1.34 | 0.03 | 0.08 | 0.11 | 0.06 |
| Net Debt to EBITDA | 2.87 | -0.44 | -0.09 | -0.28 | -0.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.42% | 66.15% | 65.86% | 64.28% | 63.33% |
| EBIT Margin | 11.92% | 21.88% | 22.88% | 23.18% | 23.38% |
| EBITDA Margin | 16.68% | 26.00% | 27.25% | 27.66% | 27.81% |
| Operating Profit Margin | 11.92% | 21.69% | 18.00% | 18.09% | 16.92% |
| Pretax Profit Margin | 13.99% | 21.79% | 22.80% | 23.12% | 23.33% |
| Net Profit Margin | 13.04% | 22.56% | 20.37% | 20.40% | 20.67% |
| Continuous Operations Profit Margin | 13.05% | 22.51% | 20.32% | 20.39% | 20.69% |
| Net Income Per EBT | 93.23% | 103.52% | 89.35% | 88.24% | 88.62% |
| EBT Per EBIT | 117.39% | 100.46% | 126.64% | 127.81% | 137.87% |
| Return on Assets (ROA) | 5.93% | 13.05% | 11.84% | 12.33% | 12.84% |
| Return on Equity (ROE) | 10.69% | 15.34% | 13.88% | 14.89% | 15.36% |
| Return on Capital Employed (ROCE) | 6.29% | 14.28% | 11.78% | 12.57% | 11.99% |
| Return on Invested Capital (ROIC) | 5.71% | 14.19% | 10.22% | 10.62% | 10.37% |
| Return on Tangible Assets | 9.01% | 16.65% | 15.53% | 16.36% | 17.82% |
| Earnings Yield | 4.96% | 10.34% | 9.49% | 8.34% | 8.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.65 | 4.15 | 4.38 | 3.84 | 3.53 |
| Payables Turnover | 4.58 | 3.57 | 4.35 | 4.28 | 3.85 |
| Inventory Turnover | 2.06 | 1.17 | 1.19 | 1.38 | 1.37 |
| Fixed Asset Turnover | 1.73 | 1.64 | 1.61 | 2.13 | 2.85 |
| Asset Turnover | 0.45 | 0.58 | 0.58 | 0.60 | 0.62 |
| Working Capital Turnover Ratio | 2.31 | 2.28 | 2.14 | 2.03 | 1.90 |
| Cash Conversion Cycle | 197.10 | 297.08 | 305.10 | 275.16 | 274.54 |
| Days of Sales Outstanding | 100.03 | 88.03 | 83.35 | 94.93 | 103.35 |
| Days of Inventory Outstanding | 176.78 | 311.30 | 305.72 | 265.45 | 265.90 |
| Days of Payables Outstanding | 79.70 | 102.26 | 83.97 | 85.22 | 94.71 |
| Operating Cycle | 276.81 | 399.33 | 389.06 | 360.38 | 369.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.25 | 0.37 | 0.33 | 0.35 | 0.27 |
| Free Cash Flow Per Share | 0.20 | 0.25 | -0.00 | 0.08 | 0.07 |
| Dividend Paid and CapEx Coverage Ratio | 1.09 | 1.32 | 0.86 | 1.08 | 1.09 |
| Capital Expenditure Coverage Ratio | 4.87 | 2.92 | 0.99 | 1.32 | 1.34 |
| Operating Cash Flow Coverage Ratio | 0.19 | 14.82 | 4.23 | 3.27 | 4.84 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.23 | 0.22 | 0.24 | 0.20 |
| Free Cash Flow Yield | 3.88% | 7.06% | -0.13% | 2.41% | 1.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.85 | 9.67 | 10.53 | 11.99 | 12.31 |
| Price-to-Sales (P/S) Ratio | 2.63 | 2.18 | 2.15 | 2.45 | 2.54 |
| Price-to-Book (P/B) Ratio | 2.16 | 1.48 | 1.46 | 1.78 | 1.89 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 25.74 | 14.17 | -792.82 | 41.52 | 50.14 |
| Price-to-Operating Cash Flow Ratio | 20.46 | 9.32 | 9.59 | 10.05 | 12.74 |
| Price-to-Earnings Growth (PEG) Ratio | -0.71 | 0.48 | 3.05 | 3.36 | 1.60 |
| Enterprise Value Multiple | 18.65 | 7.95 | 7.79 | 8.56 | 8.67 |
| Enterprise Value | 1.90B | 1.02B | 957.28M | 1.04B | 960.47M |
| EV to EBITDA | 18.65 | 7.95 | 7.79 | 8.56 | 8.67 |
| EV to Sales | 3.11 | 2.07 | 2.12 | 2.37 | 2.41 |
| EV to Free Cash Flow | 30.43 | 13.43 | -784.02 | 40.21 | 47.48 |
| EV to Operating Cash Flow | 24.19 | 8.83 | 9.48 | 9.73 | 12.06 |
| Tangible Book Value Per Share | 0.93 | 1.75 | 1.56 | 1.39 | 1.23 |
| Shareholders’ Equity Per Share | 2.39 | 2.35 | 2.16 | 1.97 | 1.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | -0.03 | 0.11 | 0.12 | 0.11 |
| Revenue Per Share | 1.96 | 1.60 | 1.47 | 1.44 | 1.37 |
| Net Income Per Share | 0.26 | 0.36 | 0.30 | 0.29 | 0.28 |
| Tax Burden | 0.93 | 1.04 | 0.89 | 0.88 | 0.89 |
| Interest Burden | 1.17 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.24 | 0.27 | 0.07 | 0.07 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.99 | 1.04 | 1.10 | 1.19 | 0.97 |
Currency in EUR

